PMC Articles for MedGen (Select 75844) - PMC

Links from MedGen

Items: 1 to 20 of 358

<< First< Prev

Page of 18

Select item 55569791.

Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016

Prashant Kapoor, Stephen M. Ansell, Rafael Fonseca, Asher Chanan-Khan, Robert A. Kyle, Shaji K. Kumar, Joseph R. Mikhael, Thomas E. Witzig, Michelle Mauermann, Angela Dispenzieri, Sikander Ailawadhi, A. Keith Stewart, Martha Q. Lacy, Carrie A. Thompson, Francis K. Buadi, David Dingli, William G. Morice, Ronald S. Go, Dragan Jevremovic, Taimur Sher, Rebecca L. King, Esteban Braggio, Ann Novak, Vivek Roy, Rhett P. Ketterling, Patricia T. Greipp, Martha Grogan, Ivana N. Micallef, P. Leif Bergsagel, Joseph P. Colgan, Nelson Leung, Wilson I. Gonsalves, Yi Lin, David J. Inwards, Suzanne R. Hayman, Grzegorz S. Nowakowski, Patrick B. Johnston, Steven J. Russell, Svetomir N. Markovic, Steven R. Zeldenrust, Yi L. Hwa, John A. Lust, Luis F. Porrata, Thomas M. Habermann, S. Vincent Rajkumar, Morie A. Gertz, Craig B. Reeder

JAMA Oncol. Author manuscript; available in PMC 2017 Sep 15.

Published in final edited form as: JAMA Oncol. 2017 Sep 1; 3(9): 1257–1265. doi: 10.1001/jamaoncol.2016.5763

PMCID:: PMC5556979

Abstract Article PDF–445K

Select item 61442092.

Genetic and Epigenetic Modulation of CD20 Expression in B-Cell Malignancies: Molecular Mechanisms and Significance to Rituximab Resistance

Akihiro Tomita

J Clin Exp Hematop. 2016 Dec; 56(2): 89–99. Published online 2016 Dec 13. doi: 10.3960/jslrt.56.89

PMCID:: PMC6144209

Abstract Article PDF–1.9M

Select item 59888453.

GMP-Grade Manufacturing of T Cells Engineered to Express a Defined γδTCR

Trudy Straetemans, Guido J. J. Kierkels, Ruud Doorn, Koen Jansen, Sabine Heijhuurs, Joao M. dos Santos, Anna D. D. van Muyden, Henri Vie, Béatrice Clemenceau, Reinier Raymakers, Moniek de Witte, Zsolt Sebestyén, Jürgen Kuball

Front Immunol. 2018; 9: 1062. Published online 2018 May 30. doi: 10.3389/fimmu.2018.01062

PMCID:: PMC5988845

Abstract Article PDF–2.5M

Select item 59931344.

Epidermal growth factor receptor (EGFR) T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non-small cell lung cancer progression during first-generation tyrosine kinase inhibitor therapy: a prospective observational study

Shirong Zhang, Lucheng Zhu, Bing Xia, Enguo Chen, Qiong Zhao, Xiaochen Zhang, Xueqin Chen, Xufeng Chen, Shenglin Ma

Cancer Commun (Lond) 2018; 38: 28. Published online 2018 May 22. doi: 10.1186/s40880-018-0303-2

PMCID:: PMC5993134

Abstract Article PDF–3.0M

Select item 59996325.

非小细胞肺癌外周血游离DNA及肿瘤细胞EGFR基因突变检测方法的研究进展

徐燕

Zhongguo Fei Ai Za Zhi. 2016 Nov 20; 19(11): 766–772. Chinese. doi: 10.3779/j.issn.1009-3419.2016.11.08

PMCID:: PMC5999632

Abstract Article PDF–1.4M

Select item 59999276.

不同治疗对肺癌患者血液循环游离DNA检测EGFR基因突变的影响及预后分析

苏飞, 郑可, 付祎云, 吴倩, 唐源, 王威亚, 蒋莉莉

Zhongguo Fei Ai Za Zhi. 2018 May 20; 21(5): 389–396. Chinese. doi: 10.3779/j.issn.1009-3419.2018.05.06

PMCID:: PMC5999927

Abstract Article PDF–1.5M

Select item 60677987.

T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma

Jennifer N. Brudno, Irina Maric, Steven D. Hartman, Jeremy J. Rose, Michael Wang, Norris Lam, Maryalice Stetler-Stevenson, Dalia Salem, Constance Yuan, Steven Pavletic, Jennifer A. Kanakry, Syed Abbas Ali, Lekha Mikkilineni, Steven A. Feldman, David F. Stroncek, Brenna G. Hansen, Judith Lawrence, Rashmika Patel, Frances Hakim, Ronald E. Gress, James N. Kochenderfer

J Clin Oncol. 2018 Aug 1; 36(22): 2267–2280. Published online 2018 May 29. doi: 10.1200/JCO.2018.77.8084

PMCID:: PMC6067798

Abstract Article PDF–1.5M

Select item 60736928.

Towards Molecular Profiling in Multiple Myeloma: A Literature Review and Early Indications of Its Efficacy for Informing Treatment Strategies

Wolfgang Willenbacher, Andreas Seeber, Normann Steiner, Ella Willenbacher, Zoran Gatalica, Jeff Swensen, Jeffery Kimbrough, Semir Vranic

Int J Mol Sci. 2018 Jul; 19(7): 2087. Published online 2018 Jul 18. doi: 10.3390/ijms19072087

PMCID:: PMC6073692

Abstract Article PDF–1.6M

Select item 60761339.

Association between advanced NSCLC T790 M EGFR-TKI secondary resistance and prognosis: A observational study

Yuli Wang, Yuan Wei, Xiaoping Ma, Xinyu Ma, Ping Gong

Medicine (Baltimore) 2018 Jul; 97(28): e11346. Published online 2018 Jul 13. doi: 10.1097/MD.0000000000011346

PMCID:: PMC6076133

Abstract Article PDF–267K

Select item 609598310.

Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy

Shih-Feng Cho, Kenneth C. Anderson, Yu-Tzu Tai

Front Immunol. 2018; 9: 1821. Published online 2018 Aug 10. doi: 10.3389/fimmu.2018.01821

PMCID:: PMC6095983

Abstract Article PDF–432K

Select item 610032211.

Anti-Proliferative Activity of HPOB against Multiple Myeloma Cells via p21 Transcriptional Activation

Linlin Liu, Xiaoyang Sun, Yu Xie, Yinping Zhuang, Ruosi Yao, Kai Xu

Molecules. 2018 May; 23(5): 1044. Published online 2018 Apr 30. doi: 10.3390/molecules23051044

PMCID:: PMC6100322

Abstract Article PDF–2.2M

Select item 613115312.

Frequent functional activation of RAS signalling not explained by RAS/RAF mutations in relapsed/refractory multiple myeloma

Kwan Yeung Wong, Qiumei Yao, Ling-Qing Yuan, Zhenhai Li, Edmond Shiu Kwan Ma, Chor Sang Chim

Sci Rep. 2018; 8: 13522. Published online 2018 Sep 10. doi: 10.1038/s41598-018-31820-9

PMCID:: PMC6131153

Abstract Article PDF–1.5M

Select item 582831613.

Inhibition of thioredoxin activates mitophagy and overcomes adaptive bortezomib resistance in multiple myeloma

Zhihong Zheng, Shengjun Fan, Jing Zheng, Wei Huang, Cristina Gasparetto, Nelson J. Chao, Jianda Hu, Yubin Kang

J Hematol Oncol. 2018; 11: 29. Published online 2018 Feb 27. doi: 10.1186/s13045-018-0575-7

PMCID:: PMC5828316

Abstract Article PDF–3.9M

Select item 622312814.

Multiple Myeloma: 2018 update on Diagnosis, Risk-stratification and Management

S. Vincent Rajkumar

Am J Hematol. Author manuscript; available in PMC 2019 Aug 16.

Published in final edited form as: Am J Hematol. 2018 Aug 16; 93(8): 981–1114. Published online 2018 Aug 16. doi: 10.1002/ajh.25117

PMCID:: PMC6223128

Abstract Article PDF–946K

Select item 624699915.

晚期肺腺癌患者一线治疗前后EGFR基因突变差异性分析

李慧, 严时, 刘显红, 柳影, 马丽霞, 王莹, 刘岩, 程颖

Zhongguo Fei Ai Za Zhi. 2018 Nov 20; 21(11): 821–827. Chinese. doi: 10.3779/j.issn.1009-3419.2018.11.03

PMCID:: PMC6246999

Abstract Article PDF–1.9M

Select item 629366016.

Whole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways

Benoît Tessoulin, Agnès Moreau-Aubry, Géraldine Descamps, Patricia Gomez-Bougie, Sophie Maïga, Alban Gaignard, David Chiron, Emmanuelle Ménoret, Steven Le Gouill, Philippe Moreau, Martine Amiot, Catherine Pellat-Deceunynck

J Hematol Oncol. 2018; 11: 137. Published online 2018 Dec 13. doi: 10.1186/s13045-018-0679-0

PMCID:: PMC6293660

Abstract Article PDF–2.2M

Select item 632513917.

Cell-based immunotherapy approaches for multiple myeloma

Katharina Kriegsmann, Mark Kriegsmann, Martin Cremer, Michael Schmitt, Peter Dreger, Hartmut Goldschmidt, Carsten Müller-Tidow, Michael Hundemer

Br J Cancer. 2019 Jan 8; 120(1): 38–44. Published online 2018 Dec 6. doi: 10.1038/s41416-018-0346-9

PMCID:: PMC6325139

Abstract Article PDF–578K

Select item 636538318.

TRIM44 promotes quiescent multiple myeloma cell occupancy and survival in the osteoblastic niche via HIF-1α stabilization

Zheng Chen, Tsung-Chin Lin, Xiaohong Bi, Guijin Lu, Brian C. Dawson, Roberto Miranda, L. Jeffrey Medeiros, Ian McNiece, Nami McCarty

Leukemia. 2019; 33(2): 469–486. Published online 2018 Aug 8. doi: 10.1038/s41375-018-0222-x

PMCID:: PMC6365383

Abstract Article PDF–2.6M

Select item 640349219.

miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone Resistance in Multiple Myeloma

Jian Xu, Yan Su, Aoshuang Xu, Fengjuan Fan, Shidai Mu, Lei Chen, Zhangbo Chu, Bo Zhang, Haifan Huang, Jiasi Zhang, Jun Deng, Lisha Ai, Chunyan Sun, Yu Hu

Mol Ther. 2019 Mar 6; 27(3): 559–570. Published online 2019 Jan 24. doi: 10.1016/j.ymthe.2019.01.012

PMCID:: PMC6403492

Abstract Article PDF–4.9M

Select item 641950620.

NTRK fusion-positive cancers and TRK inhibitor therapy

Emiliano Cocco, Maurizio Scaltriti, Alexander Drilon

Nat Rev Clin Oncol. Author manuscript; available in PMC 2019 Dec 1.

Published in final edited form as: Nat Rev Clin Oncol. 2018 Dec; 15(12): 731–747. doi: 10.1038/s41571-018-0113-0

PMCID:: PMC6419506

Abstract Article PDF–1.7M

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from MedGen

Items: 1 to 20 of 358

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity